Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab: comment()

Detalles Bibliográficos
Autores principales: Aomar-Millán, Ismael Francisco, Salvatierra, Juan, Callejas-Rubio, José Luis, Raya-Álvarez, Enrique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier España, S.L.U. 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219577/
https://www.ncbi.nlm.nih.gov/pubmed/35752586
http://dx.doi.org/10.1016/j.reumae.2022.06.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219577/
https://www.ncbi.nlm.nih.gov/pubmed/35752586
http://dx.doi.org/10.1016/j.reumae.2022.06.001

Ejemplares similares